Nice to be reminded
Conclusion: Economically, although the net profit per square centimeter of dermal template may favor IDRT, the ancillary benefits associated with BTM in terms of reduced hospital stay, shorter surgery times, fewer follow-up visits, and lower revisionary surgery rates contribute substantially to overall cost-effectiveness. Biodegradable Temporizing Matrix use reflects more efficient resource use and potential cost savings, aligning with broader trends in healthcare emphasizing value-based and patient-centered care.
https://pubmed.ncbi.nlm.nih.gov/38556669/
The Clinicians Speak, page-845
-
- There are more pages in this discussion • 162 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.36 |
Change
0.020(0.85%) |
Mkt cap ! $1.628B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.40 | $2.33 | $1.160M | 491.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5181 | $2.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.36 | 1873 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |